Jose Rodriguez Cortes, PhD^1*, Robert Albero Gallego, PhD^2*, Ioan Filip, PhD^3*, Juan Angel Patino, PhD^4*, Anisha Cooke^5*, Wen-Hsuan Lin^6*, Anouchka P Laurent^7*, Bobby B Shih^8*, Aidan Quinn^2*, Raul Rabadan, PhD^3,9*, Adolfo A. Ferrando, MD, PhD^5,10,11 and Teresa Palomero, PhD¹²

¹Institute For Cancer Genetics, New York, NY
²Columbia University, New York, NY
³Department of Systems Biology, Columbia University, New York, NY
⁴Department of Systems Biology, Columbia University, New York
⁵Institute for Cancer Genetics, Columbia University, New York, NY
⁶Department of Pathology and Cell Biology, Columbia University, New York, NY
⁷Institute For Cancer Genetics, Columbia University, New York, NY
⁸Columbia University Medical Center, New York, NY
⁹Department of Biomedical Informatics, Columbia University, New York
¹⁰Department of Pediatrics, Columbia University, New York, NY
¹¹Department of Pathology & Cell Biology, Columbia University, New York
¹²Department of Pathology and Cell Biology, Inst. for Cancer Genetics Columbia University, New York, NY

Jay A Moore^1*, Andrew M. Evens, DO, MMSc², Justin Newberg, PhD^1*, Eric A. Severson, M.D., Ph.D., MMSc¹, Jennifer Mills, PhD, MSW, MPH^1*, Jordan Carter, MD^3*, Rahul Matnani, MD^4*, Jo-Anne Vergilio, MD^1*, Sally E Trabucco, PhD¹ and Shridar Ganesan, M.D., Ph.D.^5*

¹Foundation Medicine, Inc, Cambridge, MA
²Rutgers Cancer Institute of New Jersey, Warren, NJ
³Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁴Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
⁵Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ

Donna R Edwards, MPH, PhD^1*, Pei-yu Kuo, MS^2*, Alessandro Lagana, PhD^3,4,5*, Seongjee Park^1*, Pavithra Nedumaran, MS^1*, Violetta Leshchenko, PhD^6*, Stephanie Christie, PhD^7*, Shashidhar Jatiani, PhD^8*, Julie Teruya-Feldstein, MD⁹ and Samir S. Parekh, MD¹⁰

¹Icahn School of Medicine at Mount Sinai, New York, NY
²Department of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
³Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York
⁵Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, New York, NY
⁶Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁷Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
⁸Mt Sinai Medical Center, New York, NY
⁹Department of Pathology, Molecular and Cell-Based Medicine, Hematopathology Division, Memorial Sloan-Kettering Cancer Center, New York, NY
¹⁰Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Pablo Mozas, MD^1*, Cristina López, PhD^2*, Marta Grau^2*, Sara Valle^2*, Giancarlo Castellano, PhD^2*, Alba Navarro, PhD^2,3*, Ferran Nadeu^2,3*, Blanca González-Farré, MD^4*, Alfredo Rivas-Delgado, MD¹, Andrea Rivero, MD^1*, Juan Gonzalo Correa, MD^1*, Carlos Castillo, MD^1*, Balagué Olga, MD, PhD^2,3,5*, Eva Giné, MD, PhD^1,2,3, Julio Delgado, MD, PhD^1,2,3*, Neus Villamor, MD, PhD^2,3,5*, Magda Pinyol, PhD^6*, Patricia Pérez-Galán, PhD^2,3*, Laura Magnano, MD, PhD^1,2*, Elías Campo, MD, PhD^2,3,5,7*, Anna Enjuanes, PhD^3,6*, Sílvia Beà, PhD^2,3,7* and López-Guillermo Armando, MD, PhD^1,2,3,7*

¹Hematology Department, Hospital Clínic, Barcelona, Spain
²Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
³Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
⁴Pathology Department, Hospital Clínic, Barcelona, Spain
⁵Hematopathology Unit, Pathology Department, Hospital Clínic, Barcelona, Spain
⁶Unitat de Genòmica, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
⁷Universitat de Barcelona, Barcelona, Spain

Christopher Rushton, BSc^1*, Miguel Alcaide, PhD^1*, Matthew Cheung, BSc^1*, Neil R Michaud^2*, Scott Daigle^2*, Ryan N Rys, BSc, BA^3*, Sarah E Arthur, BSc¹, Marquisa Zrymiak, BSc^1*, Jordan Davidson, BSc^1*, Kevin R Bushell, BSc, MSc^1*, Stephen Yu, MSc^1*, Michael D. Jain, MD, PhD⁴, Lois E. Shepherd⁵, Marco A. Marra, PhD⁶, John Kuruvilla, MD⁷, Michael Crump, MD⁷, Koren Kathleen Mann, PhD^8,9, Sarit E Assouline, MD, MSc⁸, Joseph M. Connors, MD¹⁰, Christian Steidl, MD¹⁰, Nathalie A Johnson, MD, PhD⁸, David W. Scott, MBChB, PhD¹⁰ and Ryan D Morin, PhD, BSc, MSc^1,6

¹Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada
²Epizyme, Cambridge, MA
³Jewish General Hospital, Lady Davis Institute For Medical Research, Montreal, QC, Canada
⁴Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁵Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada
⁶Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada
⁷Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Jewish General Hospital, Montreal, QC, Canada
⁹Lady Davis Institute for Medical Research, Montreal, QC, Canada
¹⁰Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada

Andrea J. Radtke, PhD^1*, Arthur L. Shaffer III, PhD^2*, Stefania Pittaluga, MD, PhD³, Alexander Bagaev, MS^4*, Nishant Thakur, PhD^1*, Theresa Davies-Hill, BS^3*, Olga Plotnikova, MS^4*, Ilia Galkin, MS^4*, Ekaterina Postovalova, PhD^4*, Viktor Svekolkin, MS^4*, Sergei Isaev, MS^4*, Yaroslav Lozinsky, MS^4*, Mark Meerson, MS^4*, Arina Varlamova, MS^4*, Pavel Ovcharov, MS^4*, Margarita Polyakova, MD^4*, Krystle Nomie, PhD^4*, Ekaterina Nuzhdina, MS^4*, Nikita Kotlov, MS^4*, Maria Tsiper, PhD^4*, Felix Frenkel, PhD^4*, Ravshan Attaulakhanov, PhD^4*, Nathan H Fowler, MD⁴, Ziv Yaniv, PhD^5*, Bradley C Lowekamp, PhD^5*, Michael Kelly, PhD^6*, Ezzat Dadkhah, PhD^6*, Da Wei Huang, MD^2*, Jagan R. Muppidi, MD, PhD^2*, Elaine S. Jaffe, MD³, Wyndham H. Wilson, MD, PhD², Louis M. Staudt, MD, PhD², Ronald N. Germain, MD, PhD^1* and Mark Roschewski, MD⁷

¹Lymphocyte Biology Section and Center for Advanced Tissue Imaging, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
²Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴BostonGene, Waltham, MA
⁵Bioinformatics and Computational Bioscience Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
⁶Cancer Research Technology Program, Single Cell Analysis Facility, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁷Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Xianhuo Wang, M.D.^1*, Tingting Zhang^1*, Yuhang Hong^1*, Xianming Liu^1*, Lihua Qiu^1*, Lanfang Li^1*, Zhengzi Qian^1*, Shiyong Zhou^1*, Bin Meng^2*, Kai Fu, MD, PhD^3,4 and Huilai Zhang^1*

¹Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
²Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
³Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
⁴Pathology, Univ. of Nebraska Medical Ctr., Omaha, NE

Cyril Quivoron, PhD^1*, Jean-Marie Michot Jr., MD^2*, Valérie Camara-clayette, PhD^3*, Alina Danu, MD^4*, Julien Lazarovici, MD^5*, Clementine Sarkozy, MD, PhD^6*, David Ghez, MD, PhD^7*, Julien Rossignol, MD, PhD^8*, Capucine Baldini, MD^2*, Patricia Martin-Romano, MD, PhD^6*, Helene Lecourt^3*, Veronique Vergé, MD^3*, Andrea Varga, MD^2*, Sophie Cotteret, MD, PhD^3*, Peggy Dartigues-Cuillères, MD^6*, Christophe Massard, MD, PhD^2* and Vincent Ribrag, MD³

¹Gustave Roussy, INSERM U1170, Université Paris-Saclay, Villejuif, France
²Gustave Roussy Cancer Campus, Villejuif, France
³Gustave Roussy, Villejuif, France
⁴Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
⁵Department of hematology, Gustave Roussy Cancer Campus Grand Paris, Villejuif CEDEX, France
⁶DITEP, Gustave Roussy, Villejuif, France
⁷Service d'Hématologie, Département de Médecine, Gustave Roussy Cancer Campus, Villejuif, France
⁸Hematology, Gustave Roussy, Villejuif, France

Matthew J Cross, MBBS, BSc^1*, Grzegorz Pietka, PhD^2*, Sarah Dunne^3*, Leonora Conneely^3*, Michael Hubank, PhD^4*, Corinne De Lord, MD, FRCPath^5*, Michelle Furtado, MD, FRCPath, PhD^6*, Pawel Kaczmarek, MD, PhD^7*, Dima El-Sharkawi^3*, Claire E. Dearden, MD, FRCP, FRCPath^3*, Kabir Mohammed^8*, Alan Stewart Dunlop, MSc, BS^9*, Ricardo Morilla^10*, Karol Pal, PhD^11,12*, Nikos Darzentas, PhD^12*, David Gonzalez, PhD^13*, Dorte Wren, PhD FRCPath^2* and Sunil Iyengar, MD, FRCPath, PhD^3*

¹Department of Haemato-Oncology, Royal Marsden Hospital, Sutton, ENG, United Kingdom
²Clinical Genomics, Royal Marsden Hospital, Sutton, United Kingdom
³Department of Haemato-Oncology, Royal Marsden Hospital, Sutton, United Kingdom
⁴Clinical Genomics, The Royal Marsden Hospital, Sutton, United Kingdom
⁵Epsom and St Helier University Hospitals NHS Trust, Carshalton, United Kingdom
⁶Royal Cornwall Hospital, Truro, United Kingdom
⁷Department of Haematology, Surrey and Sussex Healthcare NHS Trust, Redhill, United Kingdom
⁸Royal Marsden Hospital, London, United Kingdom
⁹Immunophenotyping, Royal Marsden Hospital, Sutton, ENG, United Kingdom
¹⁰Immunophenotyping, Royal Marsden Hospital, Sutton, United Kingdom
¹¹Department of Molecular Medicine, CEITEC MU - Central European Institute of Technology, Masaryk University, Brno, Czech Republic
¹²Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany
¹³Precision Medicine Centre of Excellence, Centre for Cancer Research & Cell Biology, Queens University Belfast, Belfast, United Kingdom

Yang Han, MM^1,2*, Ya Zhang, MD^1,2*, Xinting Hu, MM^1*, Xiang Sun, BS^1,2* and Xin Wang, MD, PhD^1,2

¹Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China

Tatsuzo Mishina, MD^1,2*, Nagisa Oshima-Hasegawa, MD, PhD^1,2*, Shokichi Tsukamoto, MD, PhD¹, Masaki Fukuyo, PhD^3*, Hajime Kageyama^4*, Bahityar Rahmutulla, MD, PhD^3*, Yurie Nagai, MD^1*, Kensuke Kayamori, MD, PhD^1*, Yutaro Hino, MD, PhD^1*, Tomoya Muto, MD, PhD¹, Shio Mitsukawa, MD, PhD^1,5*, Yusuke Takeda, MD, PhD^1*, Naoya Mimura, MD, PhD^1,5, Chikako Ohwada, MD, PhD^1,6, Masahiro Takeuchi, MD, PhD⁷, Hideki Tsujimura, MD, PhD⁷, Tohru Iseki, MD, PhD^1,5*, Chiaki Nakaseko, MD, PhD⁶, Jun-ichiro Ikeda, MD, PhD^8*, Makiko Itami, MD, PhD^4*, Koutaro Yokote, MD, PhD^2*, Osamu Ohara, PhD^9*, Atsushi Kaneda, MD, PhD^3* and Emiko Sakaida, MD, PhD^1,2

¹Department of Hematology, Chiba University Hospital, Chiba, Japan
²Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan
³Department of Molecular Oncology, Chiba University Graduate School of Medicine, Chiba, Japan
⁴Division of Surgical Pathology, Chiba Cancer Center, Chiba, Japan
⁵Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan
⁶Department of Hematology, International University of Health and Welfare, Narita, Japan
⁷Division of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan
⁸Department of Diagnostic Pathology, Chiba University Graduate School of Medicine, Chiba, Japan
⁹Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Japan